Join to View Full Profile
3500 S Lafountain StKokomo, IN 46902
Phone+1 765-453-8571
Fax+1 765-864-8789
Dr. Salter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Salter is an oncology specialist based in Kokomo, IN, with expertise in hematologic oncology. He completed his fellowship in Hematology and Medical Oncology at Indiana University School of Medicine and his residency in Internal Medicine at Kettering Health Network. He is an alumnus of Wright State University Boonshoft School of Medicine. Dr. Salter has contributed to the field through publications such as a study on Pemetrexed for Thymoma and Thymic Carcinoma in the Journal of Thoracic Oncology, and research on bleeding phenotype variability in the Amish population with hemophilia, as well as on antiangiogenic agents in breast cancer.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008
Kettering Health Network/Kettering Medical CenterResidency, Internal Medicine, 2001 - 2004
Wright State University Boonshoft School of MedicineClass of 2001
Certifications & Licensure
IN State Medical License 2005 - 2025
OH State Medical License 2003 - 2008
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology- National Board of Physicians and Surgeons Medical Oncology
Publications & Presentations
PubMed
- 38 citationsA Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma.Olumide B. Gbolahan, Ryan F. Porter, John T. Salter, Constantin T. Yiannoutsos, Matthew Burns
Journal of Thoracic Oncology. 2018-12-01 - 17 citationsVariability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.Anjali Sharathkumar, Brandon M. Hardesty, Anne Greist, John T. Salter, Bryce A. Kerlin
Haemophilia. 2009-01-01 - 11 citationsAntiangiogenic Agents in Breast CancerJohn T. Salter, Kathy D. Miller
Cancer Investigation. 2007-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
